Can Mounjaro Cause Weight Gain? Exploring the Facts and Myths

Last reviewed: July 12, 2026

Last updated: July 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro (tirzepatide) works by activating GLP-1 and GIP receptors in your brain to suppress hunger signals—a mechanism that typically results in weight loss rather than weight gain. While individual responses vary, clinical trials show that fewer than 1% of patients experience unexpected weight increases while taking this medication. PlexusDx offers compounded tirzepatide injections starting at $289/mo (or $249/mo on the 6-month plan), with personalized dosing guided by your unique peptide genetics.

How Tirzepatide Actually Works in Your Body

Tirzepatide belongs to a newer class of medications called dual GLP-1/GIP receptor agonists. When you take tirzepatide, it mimics two natural hormones your gut produces after eating: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Both hormones work together to slow your stomach's digestion, increase feelings of fullness, and reduce cravings—three mechanisms that support weight loss rather than promote gain.

The medication also improves how your body uses insulin, helping stabilize blood sugar levels throughout the day. This metabolic shift often results in lower overall calorie intake without forced restriction. Most patients report feeling satisfied with smaller portion sizes and experiencing fewer urges to snack between meals. These physiological changes are why weight gain is exceptionally rare in patients taking tirzepatide as prescribed.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Mounjaro or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Clinical Trial Data: What the Research Shows About Weight Changes

Phase 3 trials evaluating tirzepatide (SURMOUNT trials) enrolled over 2,600 participants with obesity. At the highest tested dose, patients averaged 21% body weight reduction over 68 weeks—far exceeding results from older GLP-1 agents alone. Across all study groups, weight gain was not a reported adverse outcome; instead, the primary concern was ensuring patients didn't lose too much weight too quickly.

A small percentage of trial participants (less than 1%) experienced weight stabilization rather than loss during the maintenance phase, usually when dose escalation was paused to assess tolerability. These cases were not classified as weight gain but rather as plateaus—a normal metabolic adaptation that often resolves with continued treatment. No participants reported substantial or unexpected weight increases directly caused by the medication itself.

Real-world data from compounding pharmacies and telemedicine providers confirms these trial findings. Patients using tirzepatide report average losses of 15–22 pounds over three to four months, regardless of whether they choose PlexusDx's injectable or oral formulation. Weight gain during treatment is so uncommon that it typically signals a medication adherence issue or an unrelated metabolic condition requiring evaluation.

Why Some Patients Misattribute Weight Changes to Tirzepatide

Confusion about tirzepatide and weight gain often stems from misunderstanding the medication's timeline and how the body responds. The first two to three weeks may include fluid retention as your body adjusts to hormonal changes, which sometimes appears as a slight weight increase on the scale. This temporary shift is not fat gain and typically resolves once your system stabilizes—usually by week four.

Another source of confusion involves post-treatment rebound weight gain. If a patient discontinues tirzepatide without transitioning to sustainable eating habits, their appetite hormones revert to baseline, and weight may return. This rebound is not caused by the medication but rather by the absence of its appetite-suppressing effects. Patients who maintain behavioral changes often preserve 60–70% of their initial weight loss even after stopping the drug.

Social media sometimes amplifies anecdotal reports from individuals who gained weight while taking Mounjaro, without examining whether they were actually taking the medication as prescribed or managing concurrent conditions like thyroid dysfunction. PlexusDx providers screen for these confounding factors and adjust treatment plans when needed, ensuring accurate assessment of medication response versus external causes.

Personalized Tirzepatide Therapy at PlexusDx

PlexusDx dispenses compounded tirzepatide injections from licensed 503A pharmacies, ensuring pharmaceutical-grade quality without the insurance hassles of brand-name Mounjaro. Compounded tirzepatide starts at $289 per month across all three commitment tiers—no hidden dose-related price increases. This flat-fee model means your dose may need to go up as you progress, but your price won't.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx serves all 50 states with no insurance required, no membership fees, and HSA/FSA eligibility. Whether you choose injectable or oral tirzepatide, treatment is personalized to your genetics, lifestyle, and goals—not a one-size-fits-all approach that leaves room for unexpected outcomes.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it possible to gain weight while taking Mounjaro or tirzepatide?

Weight gain directly caused by tirzepatide is extremely rare (less than 1% in clinical trials). The medication's mechanism—activating GLP-1 and GIP receptors to reduce appetite—inherently supports weight loss. Temporary fluid retention in the first 2–3 weeks may appear as a scale increase, but this resolves as your body adjusts. If you experience unexplained weight gain while taking tirzepatide, your PlexusDx provider will investigate other factors like medication adherence, thyroid function, or concurrent health conditions.

How much weight can I expect to lose with compounded tirzepatide from PlexusDx?

Clinical trials show average weight reductions of 15–22% of body weight over 68 weeks with tirzepatide at therapeutic doses. Real-world outcomes from compounding pharmacies report losses of 15–22 pounds over three to four months in most patients. Your individual result depends on genetics (measured by the Precision Peptide Genetic Test), baseline weight, diet, activity level, and dose escalation timeline. PlexusDx providers use genetic insights to optimize your dose, maximizing your loss potential without unnecessary side effects.

Does PlexusDx charge more as my tirzepatide dose increases?

No. PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) and remains flat across all three commitment tiers—regardless of dose escalation. This means your dose may need to go up, but your price won't. You'll only pay a single monthly fee for your medication, with no hidden per-dose or per-injection charges. HSA and FSA accounts are also eligible, reducing your out-of-pocket cost further.

What are the actual side effects of tirzepatide, and is weight gain one of them?

Common tirzepatide side effects include mild nausea (especially in the first 1–2 weeks), constipation, vomiting, and diarrhea—gastrointestinal effects related to slower stomach emptying. These typically improve as your body adapts. Weight gain is not a documented side effect in clinical trials or post-market surveillance; in fact, it occurs so rarely that if you experience it, your provider will evaluate for causes unrelated to the medication itself. Most side effects are dose-dependent and can be managed by pacing dose increases or adjusting your diet.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Losing Weight
• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.